FDA Pulls Avandia From US Pharmacies

Law360, New York (May 18, 2011, 8:55 PM EDT) -- The U.S. Food and Drug Administration announced Wednesday that it would restrict access to GlaxoSmithKline PLC's diabetes drug Avandia and pull it from retail pharmacies because of the drug's link to increased risks of heart attack and stroke.

After Nov. 18, Avandia will no longer be available at pharmacies, and doctors and patients will need to enroll in an FDA program in order to prescribe and receive the medicine, according to the agency.

The move is part of a risk evaluation and mitigation strategy for Avandia...
To view the full article, register now.